908 DevicesMASS -2.85%70 Return-on-Tangible-Asset is -31.39% as of Mar. 2026. GuruFocus rates MASS with a GF Score™ of 70/100 and a GF Value™ of $6.97 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 855 Medical Devices & Instruments companies, 908 Devices ranks worse than 73.57% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. 908 Devices's annualizedNet Income for the quarter that ended in Mar. 2026 was $-47.82 Mil. 908 Devices's average total tangible assets for the quarter that ended in Mar. 2026 was $152.34 Mil. Therefore, 908 Devices's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was -31.39%.
The historical rank and industry rank for 908 Devices's Return-on-Tangible-Asset or its related term are showing as below:
MASS'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -47.26 Med: -15.83 Max: 14.2
Current: -23.39
During the past 8 years, 908 Devices's highest Return-on-Tangible-Asset was 14.20%. The lowest was -47.26%. And the median was -15.83%.
MASS's Return-on-Tangible-Asset is ranked worse than 73.57% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 0.62
vs MASS: -23.39
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
908 Devices Return-on-Tangible-Asset Related Terms
908 Devices Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for 908 Devices's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MASS vs ELMD, CATX, SGHT: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, 908 Devices's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
908 Devices Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 908 Devices's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where 908 Devices's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of -31.39% mean?
908 Devices (MASS) has a Return-on-Tangible-Asset of -31.39% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on 908 Devices and its competitors. According to the industry distribution chart, 908 Devices ranks #629 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 73.6%.
Is 908 Devices' Return-on-Tangible-Asset too high?
908 Devices' current Return-on-Tangible-Asset is -31.39%. Based on the distribution chart, 908 Devices ranks #629 out of 855 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, 908 Devices has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 908 Devices' Return-on-Tangible-Asset compare to ELMD and CATX?
According to the Medical Devices & Instruments industry distribution chart, 908 Devices ranks #629 out of 855 companies for Return-on-Tangible-Asset. This places 908 Devices in the lower half of its industry. The industry median Return-on-Tangible-Asset is 0.62. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.62, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on 908 Devices and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 908 Devices's current Return-on-Tangible-Asset is -31.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 908 Devices stock overvalued right now?
Based on GuruFocus' analysis, 908 Devices (MASS) is currently considered Modestly Overvalued. The stock's GF Value™ is $6.97, compared to a current price of $7.84 — trading 12.5% above its estimated fair value. The current Return-on-Tangible-Asset is -31.39%. 908 Devices' overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For 908 Devices (MASS), the current Return-on-Tangible-Asset is -31.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 908 Devices (MASS) Overvalued in 2026?
Based on GuruFocus' analysis, 908 Devices stock appears to be overvalued.
The current stock price of $7.84 is trading 12.5% above its estimated GF Value™ of $6.97.
GuruFocus considers 908 Devices to be Modestly Overvalued.
Key valuation signals for MASS:
Return-on-Tangible-Asset: -31.39%
GF Value™: $6.97 vs. price of $7.84 (12.5% above fair value)
No single metric tells the full story. See the MASS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
70GF Score
Get the complete analysis for MASS
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MASS has been successfully added to your 
